Tag: femoropopliteal lesions
Connect the world session at LINC 2023 projects “outstanding” first-release data...
The Connect The World Session: Japan at this year’s Leipzig Interventional Course (LINC 2023, 6–9 June, Leipzig, Germany)—in collaboration with the Japanese Endovascular...
Real-world analysis demonstrates lower long-term mortality after DCB angioplasty of femoropopliteal...
In a real-world retrospective analysis, recently published in JACC: Cardiovascular Interventions, the long-term mortality rate was lower after drug-coated balloon (DCB) angioplasty than after plain...
Five-year evaluation of Zilver PTX stent in a real-world population continues...
Five-year results from a Japanese post-market surveillance study aimed at evaluating the Zilver PTX drug-eluting stent (DES) in a real-world population show consistently positive...
Paclitaxel-eluting stent loses BATTLE against bare metal stent
The BATTLE trial comparing a drug-eluting stent (Zilver PTX, Cook Medical) vs. a bare metal stent (Misago, Terumo) for the treatment of intermediate femoropopliteal...
